Aurinia Pharmaceuticals Inc. Quarterly Depreciation in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Aurinia Pharmaceuticals Inc. quarterly/annual Depreciation history and growth rate from Q1 2020 to Q1 2024.
  • Aurinia Pharmaceuticals Inc. Depreciation for the quarter ending March 31, 2024 was $4.85M, a 576% increase year-over-year.
  • Aurinia Pharmaceuticals Inc. annual Depreciation for 2023 was $606K, a 3.66% decline from 2022.
  • Aurinia Pharmaceuticals Inc. annual Depreciation for 2022 was $629K, a 5.13% decline from 2021.
  • Aurinia Pharmaceuticals Inc. annual Depreciation for 2021 was $663K, a 709% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $4.85M +$4.13M +576% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q1 2023 $717K +$30K +4.37% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q1 2022 $662K $687K -$1K -0.15% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $663K -$425K -$495K -707% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 $1.16M $200K +$200K Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $958K $200K +$200K Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $758K $688K +$676K +5633% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $82K $70K Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $12K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.